Go to the list of all blogs
published in Blogs
Jul 14, 2026
Planet Labs PBC (PL) Drops -16.7% Over the Last 30 Days Following Equity Offering

Planet Labs PBC (PL) Drops -16.7% Over the Last 30 Days Following Equity Offering

Key Takeaways

  • Planet Labs PBC (PL) declined approximately 16.7% over the last 30 days, with the closing price dropping from $31.15 on June 12 to $25.96 on July 13, continuing a sharp retreat from its all-time high of $51.76 reached in late May.
  • The primary catalyst was a post-earnings selloff following the June 4 fiscal Q1 2027 report, where a $1.5 billion at-the-market equity offering announcement triggered dilution fears despite better-than-expected revenue and EPS results.
  • Space-sector rotation toward the SpaceX IPO and broader risk-off sentiment driven by macroeconomic concerns further pressured the stock.
  • Over the last quarter, PL declined approximately 23.5%, reflecting a dramatic reversal after a multi-month rally fueled by strong defense contract wins and AI-driven product momentum.
  • Despite the drawdown, Planet Labs maintains a strong balance sheet with over $730 million in cash and a growing backlog exceeding $900 million, keeping long-term growth prospects intact.

A Closer Look at Planet Labs PBC (PL) and Its Position

Planet Labs PBC is a leading provider of daily global satellite imagery and geospatial analytics, operating the world's largest constellation of Earth-observation satellites. The company captures near-daily images of the entire planet and delivers actionable data to government, defense, intelligence, and commercial customers. Its growing suite of AI-enabled analytics products helps clients monitor environmental changes, support military operations, optimize agricultural yields, and manage supply chain risks. Competitors include BlackSky Technology, Maxar Technologies, and other remote-sensing providers, but Planet's scale, daily revisit frequency, and expanding government contract portfolio give it a differentiated position in the Earth-observation market.

PL Stock Performance Over the Last 30 Days and Quarter

Over the trailing 30-day period, PL shares fell from a closing price of $31.15 on June 12 to $25.96 on July 13, representing a decline of approximately 16.7%. The stock experienced heightened intraday volatility throughout this window, with trading ranges frequently exceeding 5% in single sessions, reflecting an active tug-of-war between dip buyers and momentum-driven sellers. I also checked comparable names using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Zooming out to the full quarter, Planet Labs stock dropped roughly 23.5% from its April 14 close of $33.93. This quarterly performance masks a major swing in sentiment: shares rallied to an all-time high of $51.76 on May 28 before undergoing a steep correction that erased more than 49% of peak value in roughly seven weeks. The reversal turned what appeared to be another strong quarter into a sharp pullback, driven by both company-specific events and external market forces.

What Drove the Recent Move in PL

The most significant catalyst during the last 30 days was the aftermath of Planet Labs' fiscal Q1 2027 earnings report, released on June 4. While the company posted record quarterly revenue of $94.2 million—up 42% year-over-year—and beat consensus EPS estimates by reporting a non-GAAP loss of $0.03 per share, the simultaneous announcement of a $1.5 billion at-the-market equity offering program caught investors off guard. The potential dilution of up to 10% triggered a 26% single-day plunge on June 5 and set off sustained selling pressure that continued throughout June and into mid-July.

Compounding the equity-offering overhang, the widely anticipated SpaceX IPO drew significant capital flows away from publicly traded space stocks, including Planet Labs. Institutional and retail investors rotated funds into the newly listed SpaceX shares, amplifying the selling in PL. Additionally, macroeconomic headwinds—including stronger-than-expected U.S. jobs data that raised concerns about potential Federal Reserve rate hikes—pushed investors toward a risk-off posture, disproportionately impacting high-growth, pre-profit companies like Planet Labs. A Blue Origin rocket explosion earlier in June further dampened sentiment across the commercial space sector.

The net loss of $138.9 million—though largely driven by a one-time, non-cash warrant revaluation of $106.5 million—contributed to negative headlines that weighed on retail sentiment. Even though the underlying operational trends remained healthy, the convergence of dilution fears, sector rotation, and macro anxiety created a powerful downdraft that has yet to fully stabilize.

The Broader Quarterly Picture for Planet Labs

The broader quarterly narrative for Planet Labs is one of a dramatic boom-and-bust cycle. In April and May, the stock surged nearly 70% from its mid-April levels, propelled by a series of high-profile defense contract wins, including a $21.9 million extension with the U.S. National Geospatial-Intelligence Agency and an eight-figure dedicated capacity deal with an international defense customer. The successful launch of three Pelican satellites—including Sweden's first sovereign reconnaissance satellite delivered just four months after contract signing—further validated the company's execution capabilities. Revenue growth accelerated, backlog swelled 72% year-over-year to $906 million, and the company achieved its third consecutive quarter under the Rule of 40 framework.

However, the stock had become priced for perfection after rallying roughly 474% over the preceding 12 months. When the Q1 report and equity offering failed to meet the market's elevated expectations, the reversal was swift and severe. The rotation into SpaceX's IPO exacerbated the decline, and by mid-July, PL had given back nearly all of its gains from the preceding two months. The quarterly performance underscores how quickly sentiment can shift in the high-beta space sector, even when underlying business fundamentals remain strong.

Exploring Trending AI Robots for Market Navigation

In my own analysis of volatile names like this one, I often review Tickeron's Trending AI Robots page for insights into algorithmically driven approaches. Tickeron hosts hundreds of AI-powered bots that trade thousands of tickers across diverse strategies, timeframes, and risk profiles, but only the most relevant and consistently high-performing bots appear in this section. Whether focused on momentum, swing trading, or longer-term trend following, these bots leverage real-time data and machine learning to identify opportunities. Traders monitoring stocks like PL may find value in exploring how AI-driven systems navigate rapid price swings and sector rotations.

Key Drivers to Watch for PL Going Forward

Looking ahead, the primary catalyst for Planet Labs will be its fiscal Q2 2027 earnings report, expected around mid-September 2026. Management guided for Q2 revenue between $102 million and $107 million with adjusted EBITDA profitability, and meeting or exceeding these targets will be crucial for restoring investor confidence. The company's ability to deploy proceeds from the ATM equity offering into accretive satellite expansion and AI product development will also be closely scrutinized.

On the macro front, Federal Reserve policy decisions regarding interest rates remain a key risk factor—any hawkish shift could further compress valuations for growth-stage space companies. Conversely, sustained geopolitical tensions that drive government demand for satellite intelligence could provide a tailwind for Planet's defense and intelligence segment. Investors should also monitor the evolving competitive landscape as SpaceX's public listing reshapes capital flows within the space economy and as other satellite imagery providers ramp up their own AI capabilities.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PL

PL's RSI Indicator climbs out of oversold territory

The RSI Indicator for PL moved out of oversold territory on July 31, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on PL as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PL just turned positive on July 31, 2026. Looking at past instances where PL's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PL advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PL entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.248) is normal, around the industry mean (10.193). P/E Ratio (0.000) is within average values for comparable stocks, (64.003). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.261). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (21.598) is also within normal values, averaging (35.983).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.24B. The market cap for tickers in the group ranges from 4.49 to 1.43T. SPCX holds the highest valuation in this group at 1.43T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 10%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 4%. VOYG experienced the highest price growth at 60%, while DFNS experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 51%. For the same stocks of the Industry, the average monthly volume growth was 42% and the average quarterly volume growth was 26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 57
SMR Rating: 79
Profit Risk Rating: 72
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
PL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
645 Harrison Street
Phone
+1 415 829-3313
Employees
1080
Web
https://www.planet.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.